Iodine deficiency, supplements affect thyroid cancer risk in children exposed to radioactive iodine

May 17, 2005

Exposure to radioactive iodines, mainly iodine 131 (I-131), in childhood is associated with an increased risk of thyroid cancer. Importantly, both iodine deficiency and supplementation appear to modify this risk, according to a new study in the May 18 issue of the Journal of the National Cancer Institute.

The accident at the Chernobyl nuclear power plant in April 1986 resulted in widespread radioactive contamination, particularly in parts of Belarus, the Russian Federation, and the Ukraine. For people living in these areas, the main radiation dose was to the thyroid and came from exposure to I-131 from drinking contaminated milk. (The thyroid uses iodine to make thyroid hormone.) It has been estimated that the thyroids of several thousand children in Belarus received I-131 doses of at least 2 Gray, a unit of absorbed radiation dose. (People are usually exposed to a background radiation from natural sources of only 1 to 2 mGy per year.) In addition, a very large increase in the incidence of thyroid cancer in young people was observed as early as 5 years after the accident in Belarus and slightly later in the Russian Federation and the Ukraine. However, important questions remained about the magnitude of the potential modifying effect of iodine deficiency, which was common in most of the affected areas at the time of the Chernobyl accident.

To evaluate the risk of thyroid cancer after exposure to radioactive iodine in childhood and investigate factors that might modify this risk, Elisabeth Cardis, Ph.D., of the International Agency for Research on Cancer in Lyon, France, and colleagues conducted a case-control study of 276 thyroid cancer patients and 1,300 control subjects in Belarus and the Russian Federation who had been age 15 years or younger at the time of the Chernobyl accident.

The researchers observed a strong dose-response relationship between radiation dose to the thyroid received during childhood and the risk of thyroid cancer. This risk was three times higher in iodine-deficient areas than in other areas. Potassium iodide supplementation was associated with one-third the risk of radiation-related thyroid cancer compared with no supplementation. Potassium iodide was used in the former Soviet Union for goiter prophylaxis and was distributed, mainly in Belarus, to children evacuated after the Chernobyl accident.

"Both iodine deficiency and iodine supplementation appear to be important and independent modifiers of the risk of thyroid cancer after exposure to I-131 in childhood. This result has important public health implications in the case of exposure to radioactive iodines in childhood that may occur after radiation accidents or during medical diagnostic and therapeutic procedures. Indeed, stable iodine supplementation in iodine-deficient populations may reduce the subsequent risk of radiation-related thyroid cancer in these situations," the authors write.

In an editorial, John D. Boice Jr., of the International Epidemiology Institute in Rockville, Md., and the Vanderbilt University School of Medicine in Nashville, Tenn., raises questions for future research on the association between thyroid cancer and exposure to I-131 in childhood. These new findings, he writes, provide "new and, if confirmed, provocative information on the risk of radiation-induced thyroid cancer and on the modifying role of diets deficient in stable iodine and of administering iodine supplements months after the exposure has occurred."
  • Article: Nicolas Gaudin, IARC Communications,, or Elisabeth Cardis,
  • Editorial: Clinton Colmenares, Vanderbilt-Ingram Cancer Center, 615-322-4747,

  • Article: Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, Khrouch V, et al. Risk of Thyroid Cancer After Exposure to 131I in Childhood. J Natl Cancer Inst 2005;97:724-32.
  • Editorial: Boice JD. Radiation-induced Thyroid Cancer--What's New? J Natl Cancer Inst 2005;97:703-5.

    Note: The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Attribution to the Journal of the National Cancer Institute is requested in all news coverage. Visit the Journal online at

    Journal of the National Cancer Institute

    Related Cancer Articles from Brightsurf:

    New blood cancer treatment works by selectively interfering with cancer cell signalling
    University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

    UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
    A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

    Breast cancer treatment costs highest among young women with metastic cancer
    In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

    Cancer mortality continues steady decline, driven by progress against lung cancer
    The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

    Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
    Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

    Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
    The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

    Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
    Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

    More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
    An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

    New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
    Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

    American Cancer Society outlines blueprint for cancer control in the 21st century
    The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

    Read More: Cancer News and Cancer Current Events
  • is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to